Pulmonary-Allergy Drug Advisory Committee; Cancellation

---
identifier: "/us/fr/E8-1959"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Pulmonary-Allergy Drug Advisory Committee; Cancellation"
title_number: 0
title_name: "Federal Register"
section_number: "E8-1959"
section_name: "Pulmonary-Allergy Drug Advisory Committee; Cancellation"
positive_law: false
currency: "2008-02-04"
last_updated: "2008-02-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E8-1959"
document_type: "notice"
publication_date: "2008-02-04"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "73 FR 6518"
fr_volume: 73
fr_action: "Notice."
---


#  Pulmonary-Allergy Drug Advisory Committee; Cancellation

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for February 20, 2008, is cancelled. This meeting was announced in the *Federal Register* of December 21, 2007 (72 FR 72737).

**FOR FURTHER INFORMATION CONTACT:**

Teresa A. Watkins, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5630 Fishers Lane (for express delivery, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512545. Please call the Information Line for up-to-date information on this meeting.

Dated: January 29, 2008.

Randall W. Lutter,

Deputy Commissioner for Policy.